Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Payables (2016 - 2025)

Ptc Therapeutics has reported Payables over the past 14 years, most recently at $45.5 million for Q4 2025.

  • Quarterly results put Payables at $45.5 million for Q4 2025, up 163.33% from a year ago — trailing twelve months through Dec 2025 was $45.5 million (up 163.33% YoY), and the annual figure for FY2025 was $45.5 million, up 163.33%.
  • Payables for Q4 2025 was $45.5 million at Ptc Therapeutics, down from $303.1 million in the prior quarter.
  • Over the last five years, Payables for PTCT hit a ceiling of $392.0 million in Q4 2023 and a floor of $17.3 million in Q4 2024.
  • Median Payables over the past 5 years was $220.8 million (2021), compared with a mean of $179.9 million.
  • Biggest five-year swings in Payables: soared 1677.06% in 2023 and later crashed 95.59% in 2024.
  • Ptc Therapeutics' Payables stood at $288.8 million in 2021, then plummeted by 90.56% to $27.3 million in 2022, then skyrocketed by 1337.52% to $392.0 million in 2023, then plummeted by 95.59% to $17.3 million in 2024, then soared by 163.33% to $45.5 million in 2025.
  • The last three reported values for Payables were $45.5 million (Q4 2025), $303.1 million (Q3 2025), and $338.9 million (Q2 2025) per Business Quant data.